INVO Bioscience (INVO) Tops Q3 EPS by $1.50

INVO Bioscience (NASDAQ: INVO) reported Q3 EPS of ($0.70), $1.50 better than the analyst estimate of ($2.20). Revenue for the quarter came in at $970 thousand versus the consensus estimate of $1.82 million.

For earnings history and earnings-related data on INVO Bioscience (INVO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c